Dr. David Lacey
SAB
Pharma
Eddingpharm
China
Biography
â€M.D. from the University of Colorado â€Former SVP of Global Research in Amgen â€Managed and advised a large portfolio of biologics from discovery to development in attractive therapeutic areas â€Discovered and developed the anti-RANKL human mAb denosumab, an emerging dual blockbuster for both osteoporosis and cancer-related bone diseases
Research Interest
Pharma